Subject(s)

Humans , Animals , Female , Adult , Middle Aged , Climacteric , Complementary Therapies , Coronary Disease , Diet , Estradiol , Phytosterols/administration & dosage , Phytosterols/antagonists & inhibitors , Phytosterols/classification , Phytosterols/therapeutic use , Hormone Replacement Therapy , Isoflavones , Osteoporosis, Postmenopausal , Placebos , Glycine max , Breast Neoplasms , Cimicifuga , Endometrial Neoplasms , Menopause , Postmenopause , Uterine Neoplasms

Subject(s)

Humans , Female , Candidiasis, Vulvovaginal/diagnosis , Candidiasis, Vulvovaginal/immunology , Candidiasis, Vulvovaginal/pathology , Candidiasis, Vulvovaginal/therapy , Diagnosis, Differential , Pregnancy Complications, Infectious , Trichomonas Infections , Vagina , Vaginosis, Bacterial , Vulvovaginitis , Contraception/methods , Candida albicans , Gardnerella vaginalis , HIV , Medical History Taking , Trichomonas vaginalis

Subject(s)

Humans , Female , Adult , Middle Aged , Breast Neoplasms , Endometrial Neoplasms , Hormone Replacement Therapy , Selective Estrogen Receptor Modulators/metabolism , Selective Estrogen Receptor Modulators/therapeutic use , Osteoporosis , Raloxifene Hydrochloride , Tamoxifen , Toremifene , Uterus , Bone Density , Estrogens , Selective Estrogen Receptor Modulators , Selective Estrogen Receptor Modulators/pharmacology , Osteoporosis, Postmenopausal/prevention & control , Raloxifene Hydrochloride , Tamoxifen , Toremifene